| scholarly article | Q13442814 |
| P356 | DOI | 10.2337/DIABETES.55.1.102 |
| P698 | PubMed publication ID | 16380482 |
| P50 | author | Aqeela Afzal | Q42843306 |
| Ronak Shah | Q56761466 | ||
| Cécile M Perrault | Q58786870 | ||
| Maria B Grant | Q88523403 | ||
| P2093 | author name string | Mark S Segal | |
| Jeffrey K Harrison | |||
| Elaine Beem | |||
| Lynn C Shaw | |||
| Sergio Li Calzi | |||
| Roger Tran-Son-Tay | |||
| Anna Schuler | |||
| Kyunghee Chang | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 102-109 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes | |
| P478 | volume | 55 |
| Q36720543 | Activation of the ACE2/angiotensin-(1-7)/Mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors |
| Q36112416 | Advanced glycation end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cells |
| Q41763265 | Altered SDF-1-mediated differentiation of bone marrow-derived endothelial progenitor cells in diabetes mellitus. |
| Q27013698 | An ocular view of the IGF-IGFBP system |
| Q40881340 | Angiogenic dysfunction in bone marrow-derived early outgrowth cells from diabetic animals is attenuated by SIRT1 activation |
| Q35221390 | Blockade of NADPH oxidase restores vasoreparative function in diabetic CD34+ cells |
| Q33927282 | CD34+ cells represent highly functional endothelial progenitor cells in murine bone marrow |
| Q39330643 | Camel whey protein improves lymphocyte function and protects against diabetes in the offspring of diabetic mouse dams |
| Q36842645 | Carbon monoxide and nitric oxide mediate cytoskeletal reorganization in microvascular cells via vasodilator-stimulated phosphoprotein phosphorylation: evidence for blunted responsiveness in diabetes |
| Q35070554 | Cell-based therapies for diabetic complications |
| Q37879584 | Cell-based therapies for diabetic retinopathy |
| Q37780204 | Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction |
| Q35609188 | Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationale |
| Q33649275 | Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies. |
| Q33590446 | Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock |
| Q54489626 | Differential MMP-9 activity in CD34⁺progenitor cell-derived foam cells from diabetic and normoglycemic patients. |
| Q37589340 | Differential gene expression in Lin-/VEGF-R2+ bone marrow-derived endothelial progenitor cells isolated from diabetic mice |
| Q26781269 | Dipeptidyl Peptidase-4 Regulation of SDF-1/CXCR4 Axis: Implications for Cardiovascular Disease |
| Q38912469 | Dipeptidyl peptidase-4 inhibition: insights from the bench and recent clinical studies |
| Q87690397 | Dipeptidyl peptidase-4 inhibitors are associated with improved left ventricular diastolic function after acute myocardial infarction in diabetic patients |
| Q28751480 | Distinct kinin-induced functions are altered in circulating cells of young type 1 diabetic patients |
| Q58754803 | Dysfunction and Therapeutic Potential of Endothelial Progenitor Cells in Diabetes Mellitus |
| Q34577875 | Dysfunction of circulating endothelial progenitor cells in type 1 diabetic rats with diabetic retinopathy |
| Q37699662 | EPCs and pathological angiogenesis: when good cells go bad. |
| Q42092958 | Editorial: Cell-Based Therapies for Diabetic Microvascular Complications |
| Q37395307 | Effects of diabetes on the eye. |
| Q35600400 | Effects of undenatured whey protein supplementation on CXCL12- and CCL21-mediated B and T cell chemotaxis in diabetic mice |
| Q37679623 | Endothelial progenitor cells and endothelial vesicles - what is the significance for patients with chronic kidney disease? |
| Q41810175 | Endothelial progenitor cells homing and renal repair in experimental renovascular disease |
| Q37066764 | Endothelial progenitor cells in neovascularization of infarcted myocardium |
| Q34433667 | Endothelial progenitor dysfunction in the pathogenesis of diabetic retinopathy: treatment concept to correct diabetes-associated deficits |
| Q35041129 | Enhancing the function of CD34(+) cells by targeting plasminogen activator inhibitor-1 |
| Q26859263 | Epigenetic Changes in Endothelial Progenitors as a Possible Cellular Basis for Glycemic Memory in Diabetic Vascular Complications |
| Q37126309 | Evaluation of stability and sensitivity of cell fluorescent labels when used for cell migration |
| Q36842424 | Fructose induces the inflammatory molecule ICAM-1 in endothelial cells |
| Q80735257 | Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes |
| Q36739740 | Global remodeling of the vascular stem cell niche in bone marrow of diabetic patients: implication of the microRNA-155/FOXO3a signaling pathway |
| Q34355975 | Growth factors/chemokines in diabetic vitreous and aqueous alter the function of bone marrow-derived progenitor (CD34⁺) cells in humans |
| Q50085138 | Hematopoietic stem/progenitor involvement in retinal microvascular repair during diabetes: Implications for bone marrow rejuvenation. |
| Q37057022 | Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis |
| Q35973411 | IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development |
| Q35892696 | Imbalances in Mobilization and Activation of Pro-Inflammatory and Vascular Reparative Bone Marrow-Derived Cells in Diabetic Retinopathy |
| Q37109989 | Immunological mechanisms in the pathogenesis of diabetic retinopathy |
| Q36910839 | Impaired Mobilization of Vascular Reparative Bone Marrow Cells in Streptozotocin-Induced Diabetes but not in Leptin Receptor-Deficient db/db Mice. |
| Q33352448 | Impaired collateral recruitment and outward remodeling in experimental diabetes |
| Q51026956 | Increase in acid sphingomyelinase level in human retinal endothelial cells and CD34+ circulating angiogenic cells isolated from diabetic individuals is associated with dysfunctional retinal vasculature and vascular repair process in diabetes. |
| Q35842603 | Inhaled NO contributes to lung repair in piglets with acute respiratory distress syndrome via increasing circulating endothelial progenitor cells |
| Q34718887 | Insulin resistance impairs circulating angiogenic progenitor cell function and delays endothelial regeneration |
| Q37101882 | Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells |
| Q37127713 | Labeling of stem cells with monocrystalline iron oxide for tracking and localization by magnetic resonance imaging |
| Q36410637 | Liver X receptor modulates diabetic retinopathy outcome in a mouse model of streptozotocin-induced diabetes |
| Q58110029 | Mitochondrial Depolarization Stimulates Vascular Repair-Relevant Functions of CD34 Cells via Reactive Oxygen Species-Induced Nitric Oxide Generation |
| Q30503408 | Modified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic mice |
| Q37655580 | Molecular mechanisms underlying the activation of eNOS. |
| Q34576158 | N-3 polyunsaturated Fatty acids prevent diabetic retinopathy by inhibition of retinal vascular damage and enhanced endothelial progenitor cell reparative function |
| Q37013867 | Nerve growth factor promotes endothelial progenitor cell-mediated angiogenic responses |
| Q35086114 | Nitric oxide synthase gene transfer restores activity of circulating angiogenic cells from patients with coronary artery disease |
| Q35287252 | Nitric oxide-donating statin improves multiple functions of circulating angiogenic cells. |
| Q36465965 | Nontuberculous mycobacterial osteomyelitis |
| Q35061266 | Number and function of bone-marrow derived angiogenic cells and coronary flow reserve in women without obstructive coronary artery disease: a substudy of the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) |
| Q35775471 | Oral supplementation of diabetic mice with propolis restores the proliferation capacity and chemotaxis of B and T lymphocytes towards CCL21 and CXCL12 by modulating the lipid profile, the pro-inflammatory cytokine levels and oxidative stress |
| Q33518262 | Paracrine modulation of CXCR4 by IGF-1 and VEGF: implications for choroidal neovascularization |
| Q36477259 | Per2 mutation recapitulates the vascular phenotype of diabetes in the retina and bone marrow. |
| Q36268517 | Photobiomodulation laser and pulsed electrical field increase the viability of the musculocutaneous flap in diabetic rats |
| Q36839005 | Promise of endothelial progenitor cell for treatment of diabetic retinopathy |
| Q52560208 | Reduction of Endoplasmic Reticulum Stress Improves Angiogenic Progenitor Cell function in a Mouse Model of Type 1 Diabetes. |
| Q36142209 | Restoration of Hydrogen Sulfide Production in Diabetic Mice Improves Reparative Function of Bone Marrow Cells |
| Q37383408 | Role of Acid Sphingomyelinase in Shifting the Balance Between Proinflammatory and Reparative Bone Marrow Cells in Diabetic Retinopathy. |
| Q33649297 | Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential |
| Q38236202 | Significance of CXCL12 in type 2 diabetes mellitus and its associated complications |
| Q38603660 | Stem cell therapies in the treatment of diabetic retinopathy and keratopathy |
| Q34137714 | Stepwise optimization of the procedure for assessment of circulating progenitor cells in patients with myocardial infarction. |
| Q37999783 | Strategies to reverse endothelial progenitor cell dysfunction in diabetes |
| Q35758758 | Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism |
| Q37728038 | Supplementation with Phycocyanobilin, Citrulline, Taurine, and Supranutritional Doses of Folic Acid and Biotin-Potential for Preventing or Slowing the Progression of Diabetic Complications |
| Q38195528 | The endothelium in diabetic nephropathy |
| Q37276042 | The promise of cell-based therapies for diabetic complications: challenges and solutions |
| Q38762998 | The role of dyslipidemia in diabetic retinopathy |
| Q26852080 | The unfolded protein response in retinal vascular diseases: implications and therapeutic potential beyond protein folding |
| Q34024355 | Transient inhibition of transforming growth factor-beta1 in human diabetic CD34+ cells enhances vascular reparative functions |
| Q35142725 | Vasoreparative dysfunction of CD34+ cells in diabetic individuals involves hypoxic desensitization and impaired autocrine/paracrine mechanisms |
| Q33418301 | cGMP-dependent protein kinase I is crucial for angiogenesis and postnatal vasculogenesis |
Search more.